Literature DB >> 897590

(D)-penicillamine treatment in systemic sclerosis (scleroderma). Effect on nutritional capillary circulation.

H Mellstedt, B Fagrell, G Holm, M Björkholm.   

Abstract

Four patients with systemic sclerosis (scleroderma) were treated with (D)-penicillamine (1.2-1.8 g/d) for 18-60 months. All patients improved. Vital capillary microscopy demonstrated that the number of visible skin capillaries increased during therapy, thus indicating a more efficient nutritional circulation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 897590     DOI: 10.3109/03009747709095427

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  1 in total

Review 1.  Penicillamine in the treatment of systemic sclerosis.

Authors:  P J Clements
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.